view from acot - triumf · view from acot remarks on triumf ... installation and commissioning 2....

Canada’s National Laboratory for Particle and Nuclear Physics Laboratoire national canadien pour la recherche en physique nucléaire

et en physique des particules

View from ACOTRemarks on TRIUMF performance and plans

David B. MacFarlane | Chair of ACOT

NRC International Peer Review | Nov 14, 2013

Owned and operated as a joint venture by a consortium of Canadian universities via a contribution through the National Research Council Canada

Propriété d’un consortium d’universités canadiennes, géré en co-entreprise à partir d’une contribution administrée par le Conseil national de recherches Canada

ACOT Role• Provide assurance and advice to NRC and the

Government of Canada:Government of Canada:– Effectiveness of its substantial investment in TRIUMF– Including its support for facility and infrastructureIncluding its support for facility and infrastructure

needs of the Canadian science community• Provide advice to the TRIUMF Director:

– Laboratory management, planning, strategic direction, operations and priorities

• Format for TRIUMF assessment– Biannual 2-day reviews covering full spectrum of

activities and providing feedback in a written reportactivities and providing feedback in a written report

14 Nov 2013 View from ACOT 2

ACOT Membership• Members

– Ilan Ben-Zvi, BNL [Accelerator]• Observers

– Michael Roney, Institute of , [ ]– Stephen Blundell, Oxford [CMMS]– Kerstin Borras, DESY [HEP]

Cliff Burgess McMaster [HEP]

yParticle Physics

– Garth Huber, Institute of Nuclear Physics– Cliff Burgess, McMaster [HEP]

– Jacques Lettry, CERN [Accelerator]D id M F l SLAC [Ch i ]

y– Samir Boughaba, Team

Leader, NSERC– Dugan O’Neil, Chair, NSERC– David MacFarlane, SLAC [Chair]

– Paul Mantica, NSCL [NP]– Brad Sherrill, FRIB [NP]

Dugan O Neil, Chair, NSERC Subatomic Physics GSC

– Paul Young, Chair, TRIUMF BOM

– Michel Têtu, Laval (emeritus) [Technology]

– Scott Wilbur, Washington

BOM

g[Nuclear Medicine]


Recent TRIUMF reviews• Review of May 30-June 1

N l t d t th t t f– Normal assessment and report on the state of TRIUMF to NRC

– Based on presentations, provided feedback toBased on presentations, provided feedback to TRIUMF management on draft 5-Year Plan

• Review of Oct 4-5– Abbreviated assessment and report on the state of

TRIUMF to NRCF 5 Y Pl f db k t TRIUMF– Focus on 5-Year Plan, feedback to TRIUMF management on early presentations, and preparation for input to the International Peer Review Committee


Focus issues for Oct 20131. Integrated manpower plan for the upcoming 2014

shutdown and remaining ARIEL constructionshutdown and remaining ARIEL construction, installation and commissioning

2. Planning and resources required for the Ultra-Cold Neutron experimental program

3. Update on the BL1A repair strategy4 Update on staff renewal for the nuclear medicine4. Update on staff renewal for the nuclear medicine

program5. Update on the evolution of AAPS and the overall p

technology transfer program


Focus issues for Oct 20131. Integrated manpower plan for the upcoming 2014

shutdown and remaining ARIEL constructionshutdown and remaining ARIEL construction, installation and commissioning

2. Planning and resources required for the Ultra-Cold Neutron experimental program

3. Update on the BL1A repair strategy 4 Update on staff renewal for the nuclear medicine4. Update on staff renewal for the nuclear medicine

program 5. Update on the evolution of AAPS and the overall p

technology transfer program


Highlights• Vibrant nuclear and particle physics program

– Higgs discovery with ATLAS (& CMS) at CERNgg y ( )– Appearance measurement of 13 at T2K– Cold anti-hydrogen trapping & microwave

t ith ALPHA t CERNspectroscopy with ALPHA at CERN– Exploration of 3N forces in neutron-rich nuclei, weak

binding in halo nuclei Li-11binding in halo nuclei Li 11– Study of superallowed Fermi beta decays including

mass measurements & determination of CKM Vud

– Study of hyperfine transitions in Fr, as a component of PNC program to determine nuclear weak chargeCharacterization of processes relevant to F 18– Characterization of processes relevant to F-18 destruction in stellar media


Highlights• Accelerator science, operations, & capability

improvement very impressiveimprovement very impressive– Cyclotron & ISAC performance outstanding and

subject to continuous improvementj p– Ongoing RIB development program including high

mass delivery, actinide target program, TRILIS– Systematic approach to shutdowns, improvements in

ISOC target reliability, cyclotron upgrades– Development of accelerator research program aided– Development of accelerator research program aided

by significant NSERC funding


Highlights• ARIEL ambitious but progressing well

P j t ith i h d l l di t h 1– Project with aggressive schedule leading to phase 1 completion by Sep 30, 2014

– ARIEL building turned over provisionally Aug 1, 2013ARIEL building turned over provisionally Aug 1, 2013– Delivery from PAVAC of first 9-cell SC cavity on May

28, 2013 was a key technical achievement– Overall delay in technical component delivery leading

to significant schedule compression for installation & commissioningcommissioning

– TRIUMF working hard to devise alternative solutions for assembly & testing to maintain Sep 30 milestone


Highlights• Unique molecular and material science

capabilitycapability– Completion of BL9 (TRIUMF) & B20 (CFI) in major

expansion of capabilityp p y– Impressive user program of condensed matter

physics and chemistry – Combination of muon spin resonance & unique beta-

NMR probes– Measurements of new iron-based superconductors– Measurements of new iron-based superconductors,

Li-ion battery materials, & magnetic interfaces between two non-magnetic oxides, & defect studies in

d ti itisuperconducting cavities14 Nov 2013 View from ACOT 10

Highlights• Nuclear Medicine program active & growing

O i i l t d ti f i t– Ongoing progress in cyclotron production of isotopes, production of radiopharmaceuticals for collaborative studies, & development of new radiopharmaceuticals

– Ongoing very promising effort to demonstrate a cyclotron method for producing Tc-99m in the place of reactor productionreactor production

• AAPS has now evolved to the commercialization arm for TRIUMFarm for TRIUMF– Pursuing promising developments for cosmic ray

geotomography, IKOMED shutter technology


5YP overall impressions• Three overlapping themes frame the plan very

well and tie well to proposed science &well and tie well to proposed science & investments – Targeted involvement in global projects aligned withTargeted involvement in global projects aligned with

Canadian subatomic community– Suite of ISAC experiments served by investments in

RIB capability– Continuation of ARIEL a natural & exciting evolution

of current 5YP & phased approach with science atof current 5YP & phased approach with science at each stage is compelling

– Proposal for IAMI would continue broad visibility, impact & success of Nuclear Medicine program


5YP Budgets• Inflation has seriously eroded the core TRIUMF program

over the last 10 yearsover the last 10 years – Clear loss of staff over the course of current 5YP has left

TRIUMF bare bones in terms of supporting future science, operations and developmentoperations, and development

• If extended again in the next 5YP, this would be very damaging to TRIUMF leadership in all areas

• Scenario A makes a strong case for restoration of buying power to maintain core capabilities of TRIUMF

• Alternative outcomes lead to clear impacts and• Alternative outcomes lead to clear impacts and articulated loss of capability, and limit TRIUMF’s ability to attract substantial funding outside NRC


Program Elements


IPRC performance questions• Q2. To what extent are TRIUMF’s research activities, on

a national and international scale considered leadinga national and international scale, considered leading edge?

• Q3. To what extent has key knowledge been generated as a result of TRIUMF’s activities?

• Q4. To what extent has TRIUMF enhanced and/or sustained Canada’s reputation and internationalsustained Canada s reputation and international leadership in physics?

• Q5. To what extent is TRIUMF supporting the development and training of students and postdoctoral researchers?


IPRC performance questions• Q6. How appropriate are TRIUMF’s activities related to

technology transfer and commercialization? Howtechnology transfer and commercialization? How effective have they been in enabling the Canadian industry to become more competitive?

I l d t f th AAPS d l d it– Includes an assessment of the AAPS model and its effectiveness

• Q7. Have there been unintended outcomes (positive or negative) as a result of TRIUMF’s activities?

• Q8. To what extent do TRIUMF’s governance and management models effectively support its objectives?management models effectively support its objectives? Are there gaps or redundant elements that inhibit progress or economies?


Accelerator Science & Technology



2. Leading edge activities at TRIUMFHi h t t d i b t 50 kW– Highest-power proton driver beam at 50 kW

– ISOL targets and materials– Ion source technology such as the RF Ion Guide– Ion source technology, such as the RF Ion Guide

Laser ion source, for improved yield of rare isotopes– Low intensity diagnostics for rare isotope beams– Superconducting RF (SCRF) accelerators

3. Key knowledge generated– In connection with SCRF

• Development of the ISAC II high-performance quarter-wave resonator accelerator modulesresonator accelerator modules


Accelerator Science & Technology• ARIEL as a high average current, CW superconducting

electron accelerator

– In connection with ISOL• High mass RIB delivery to ISAC II• Actinide targets program developedActinide targets program developed• Ti:Sa RILIS delivery expanded to 24 elements

– In connection with accelerator research• Non-Scaling Fixed-Field Alternating Gradient accelerator

demonstrator EMMA in Daresbury, UK• Development of a dielectric wave-guide to feed 650 MHz RF

to an electron gun• Demonstration of an Allison scanner emittance measurement

of electrons



4. Enhancement of Canadian reputationR i d i t ti l t f t & l t– Recognized international center for proton & electron accelerators, rare isotope beams, & associated technologies

5. HQP training– Unique facilities and cutting edge research

opportunities in accelerator science & technology, in connection with Canadian university partners

6 Technology transfer and commercialization6. Technology transfer and commercialization– PAVAC (SCRF cavities/cryomodules), Advanced

Cyclotron Systems (high resolution separator), & D-y y ( g p ),Pace (Ion sources)



• StrengthsW ld l ti i l t i l di d li– World class expertise in cyclotrons, including delivery of highest intensity 500 MeV class proton-beam on RIB target

– World class expertise in SCRF science & technology– World class expertise in targetry, remote handing,

d i t ti t h land isotope separation technology• Opportunities

P t ti l t b th ld’ hi h t RIB d ti– Potential to be the world’s highest RIB production rates with three separate sources, including neutron & proton rich isotopes


Accelerator Science & Technology– Core SCRF capability & related R&D as a foundation

for future facility development in Canada & worldwidey p– Expanded accelerator research & education program

providing unique training access in Canada• Vulnerabilities

– Simultaneous demands of cyclotron & ARIEL linacoperations support with limited staffoperations support with limited staff

– Aging beamline & laboratory infrastructure could lead to reduced efficiency of beam delivery

– Target module reliability & maintenance, including cycle time for repairs & limited expert staffingT h i l t i l di h t t– Technical systems, including e-photon converter


Accelerator Priorities & Plans

• Priorities for the cyclotron & ARIEL are well conceived & within the capabilities of TRIUMFconceived & within the capabilities of TRIUMF– Completing ARIEL & expanding ISOL capabilities,

upgrades to cyclotron, & initial ARIEL operationspg y , p– Improvements to accelerator operations, including

three beam delivery to users• Building on SCRF capability with R&D program

will enable future opportunities• Further development of accelerator research &

education is strongly encouraged


Nuclear Physics


Nuclear Physics2. Leading edge activities at TRIUMF

ISAC i ld l i d ti di ti l i &– ISAC is world class in production radioactive nuclei & unique in several ways:

• Acceleration of radioactive beams to CoulombAcceleration of radioactive beams to Coulomb barrier energies & above for wide mass range

• TITAN Penning trap mass spectrometer coupled to h t t b da charge state breeder

• High mass resolution DRAGON spectrometer with gas target for direct measurement of radiativegas target for direct measurement of radiativecapture reaction rates

• TIGRESS 4 segmented G2 detector for -ray t ith di ti bmeasurements with radioactive beams


Nuclear Physics– Leading laboratory for fundamental interactions

studies using low-energy methods:studies using low energy methods: • Precise determination of the CKM Vud matrix

element• Fr trap for PNC measurements & Rn atomic EDM

searchInternational groups from Japan (Osaka beam line)– International groups from Japan (Osaka beam line), UK (TUDA, SHARC), and Germany (charge state breeder) have made significant investments in ISAC


Nuclear Physics3. Key knowledge generated

N l St t– Nuclear Structure:• Precision masses of neutron-rich Ca isotopes;

weak binding in halo nuclei Be-10, Li-11weak binding in halo nuclei Be 10, Li 11– Nuclear Astrophysics:

• Understanding of F-18(p,) & destruction of F-18 in stellar media; He-3, He-4 cross sections related to Big Bang cosmology and solar neutrino production

Weak Interactions:– Weak Interactions:• Superallowed Fermi beta decays, precision mass

measurements (for Q value), collinear laser spectroscopy, & studies of Fr system for PNC


Nuclear Physics4. Enhancement of Canadian reputation

C d h f th ld’ l di l– Canada has one of the world’s leading nuclear science programs

– Innovation & productive world-class science programInnovation & productive world class science program advancing our knowledge of nuclear structure, nuclear astrophysics & weak interactionsQ5. HQP training

– Access to and training in cutting edge technology and world class science for Canadian students andworld-class science for Canadian students and postdocs


Nuclear Physics• Strengths

P d ti t f di ti lid ith– Production rates of radioactive nuclides with new capabilities for heavy nuclei & r-process path nuclei

– Accelerated beams of radioactive isotopes aboveAccelerated beams of radioactive isotopes above Coulomb barrier for nuclear structure and reactions, with specialized experiments TIGRESS & EMMAS f l l t t ( d– Synergy of low-energy nuclear structure (and reactions) theory and experiment

– Systematic approach to (nuclear physics) problemSystematic approach to (nuclear physics) problem solving with wide range of tools

– Established experimental infrastructure well-matched t t i l d ti itto meet science goals and active user community


Nuclear Physics• Opportunities

ARIEL ti l l ith it d ti f i t– ARIEL, particularly with its production of intense beams of fission fragments & multi-beam capabilities

– Model of success in leveraging resources to enhanceModel of success in leveraging resources to enhance research infrastructure

– Shuttering of other user operations (e.g., HRIBF at ORNL d d h t th f iliti ld id )ORNL, reduced hours at other facilities worldwide)

– Only facility in Canada with focus on nuclear physics• Vulnerabilities• Vulnerabilities

– High reliance on postdocs for operation of equipment & lack of continuity without permanent staffy p


Nuclear Physics– Ability to attract (more senior) scientific talent

Keeping ahead of similar accelerated radioactive– Keeping ahead of similar accelerated radioactive beam opportunities at CERN, GANIL, MSU, ANL

– Reliability of accelerator facilities to deliver full yplanned operational hours of stable & radioactive beamsDifficulty of production targets & developing new– Difficulty of production targets & developing new beams

– Insufficient technical support to maintain/upgrade pp pgexperimental infrastructure

– State-of-the art experimental facilities supported by aged infrastructure (e g utilities)aged infrastructure (e.g. utilities)


Nuclear Physics Priorities & Plans

• Completion of ARIEL is critical for realizing goals in nuclear structure nuclear astrophysics &in nuclear structure, nuclear astrophysics, & weak interactions– Phase 2: Improved ability for isolating & acceleratingPhase 2: Improved ability for isolating & accelerating

high mass isotopes in ISAC-II & study of nuclei over a much broader range

– Phase 3: Very neutron-rich nuclei critical for r-process studies & testing of predictive theories

– Phase 4: Establish Fr PNC Fr EDM & Rn EDM limits– Phase 4: Establish Fr PNC, Fr EDM & Rn EDM limits– Phase 5: Further enhance access to r-process nuclei

defining A ~ 160 rare earth abundance peak, likely critical for identification of r-process site


Particle Physics


Particle Physics2. Leading edge activities at TRIUMF

A l t t h l i– Accelerator technologies: LHC kicker magnets; high power target/remote handling for T2K

– Detector design and construction: gLAr hadronic endcap calorimeter & forward calorimeter for ATLAS; fine grain detector & TPC for near detector for T2K

– Electronics and DAQ development:Electronics and DAQ development: FGD & TPC electronics, DAQ, & slow controls

– Computing and software: ATLAS Tier 1 CenterATLAS Tier 1 Center

– Scientific leadership and physics analysis: ATLAS, T2K, and ALPHA & strong theory effort with close

li t i t lcoupling to experimental program


Particle Physics3. Key knowledge generated

I ti ith ATLAS d th LHC– In connection with ATLAS and the LHC• Higgs discovery and recent spin analysis• Searches for new physics extended into• Searches for new physics extended into

unexplored higher mass regions– In connection with K2K and JPARC

• Off-axis concept and key oscillation analysis leading to definitive observation of e appearance from beamfrom beam

– In connection with ALPHA• First trapping of anti-hydrogen & microwave pp g y g

spectroscopy14 Nov 2013 View from ACOT 35

Particle Physics4. Enhancement of Canadian reputation

W ll d d t ib ti t j i t ti l– Well regarded contributions to major international experiments and facilities at the leading edge of discovery in particle physics worldwide

5. HQP training– Access to and training in cutting edge technology and

world-class science for Canadian students and postdocs


Particle Physics• Strengths

– Well established capabilities & facilities for design &– Well established capabilities & facilities for design & construction of detectors, electronics systems, DAQ & computing

– Close coupling & collaboration with national subatomic physics community across Canada, including Universities, SNOLab, & Perimeter Instituteincluding Universities, SNOLab, & Perimeter Institute

– Intellectual leadership and broad engagement in physics output from leading international experiments,

i h i hwith strong ties to theory program– Canada’s contribution to the international laboratory

network in subatomic physics providing an entrée tonetwork in subatomic physics, providing an entrée to international collaboration


Particle Physics• Opportunities

U d t ATLAS f hi h l i it LHC & Ti 1– Upgrades to ATLAS for high-luminosity LHC & Tier-1 Center to accommodate anticipated dataset

– Development of UCN facility enabling experimentsDevelopment of UCN facility enabling experiments with world-leading sensitivity to neutron EDM

• Vulnerabilities– Sustaining core detector manpower & facilities to

enable future collaborative CFI & NSERC proposals for particle physics applicationsfor particle physics applications

– Technical challenges to UCN program, including accelerator beam requirements


Particle Physics Priorities & Plans

• TRIUMF particle physics plans aligned with Canadian national prioritiesCanadian national priorities– Supporting ATLAS upgrades, neutrinos at T2K and

HyperK, ALPHA anti-hydrogen program, and UCN yp , y g p g ,facility

– Engaging in SNOLab experimental program, including di t h f D k M tt & EXOdirect searches for Dark Matter & nEXO

– Establishing closer ties to SNOLab & the Perimeter Institute theory program an important developmentInstitute theory program an important development

• Engagement in major detector projects requires sustained core instrumentation capabilityp y


Molecular and Material Science


Molecular & Material Science2. Leading edge activities

SR d b t NMR i t ti ll– muSR and beta-NMR programs are internationally leading and very productive scientifically

3 Key knowledge generated3. Key knowledge generated– Unique information about superconductivity, its

relationship with magnetism, and problems in nanoscience have been addressed

4. Enhancement of Canadian reputation– Very strong in condensed matter physics, particularly

in the areas of magnetism and superconductivity


Molecular & Material Science5. HQP training

W ki t f ilit i it l b id– Working at a facility versus a university lab, provides important & unique training for students and postdoctoral researchers

8. Effectiveness of TRIUMF management– Risk that TRIUMF may underestimate the value of the

science produced by the muSR & beta-NMR facilities outside of mainstream subatomic physics role


Molecular & Material Science• Strengths

W ld i biliti ith th bl– World-unique capabilities with no other comparable facilities in North America

– Fundamental science but close to applications, withFundamental science but close to applications, with both bulk (μSR) and surface (βNMR) capability

– Effectively leverages Universities and adds enormous l ith l di i ti tvalue with many leading scientists among users

– Substantially adds to international competitiveness of condensed matter science in Canadacondensed matter science in Canada

• Opportunities– User base can be grown in Canada, US and Asiag ,


Molecular & Material Science– βNMR far from being fully exploited, with significant

science opportunitiesscience opportunities– Enhanced capability with MORE (muons on request),

next generation μSR spectrometers, upgraded sample environments on βNMR

• VulnerabilitiesU b tl ll th id l– User base currently smaller than ideal

– Beam application oversubscription rates too lowLevel of staff support low & vulnerable to loss of– Level of staff support low & vulnerable to loss of expertise

– Highly vulnerable to equipment failure on aging cyclotron beamlines


MMS Priorities and Plans• Material science program scientifically strong

and should be supportedand should be supported– Provides TRIUMF with broader scientific output in a

way that is highly leveraged on core subatomic y g y gprogram

• Potentially significant benefits to Canadian material science from modest growth in NRC core support for MMS

C t b fit l i h ld b f d i i– Cost-benefit analysis should be performed on waiving user fees to grow the science strength, as well as instrument scientist staffingg


Nuclear Medicine


Nuclear Medicine2. Leading edge activities

C l t t t l t d ti f T 99– Cyclotron targetry, cyclotron production of Tc-99m, PET radionuclides, & development of radiochemistry for producing radiopharmaceuticals for neurotransmitter research

3. Key knowledge generated– In connection with cyclotron production of Tc-99m

• Engineering of cyclotron targets,I di ti t f i i i d ti• Irradiation parameters for maximizing production

• Purification methods for isolation of Tc-99m• Methods for recycling Mo-100Methods for recycling Mo-100


Nuclear Medicine4. Enhancement of Canada’s reputation

N h t T 99 d ti– New approaches to Tc-99m production5. HQP training

Very strong program in many areas including:– Very strong program in many areas, including: cyclotron target design, commissioning/testing, operation, radiochemistry, radiopharmaceutical chemistry, molecular imaging

6. (a) Technology transfer and commercialization– Tc-99m research is set-up to be commercialized– PET radionuclide production may be

commercializablecommercializable


Nuclear Medicine– Radiochemistry & radiopharmaceutical development

may lead to commercializable methods & productsmay lead to commercializable methods & products– Paul Schaffer recognized as member of 2014

Business in Vancouver Top 40 under 406. (b) Enabling of Canadian industry

– Examples include work with Nordion and Advanced C l t S tCyclotron Systems

8. Effectiveness of TRIUMF managementP id ti i t f ti– Provides a very supportive environment for operation and future growth of the Nuclear Medicine Division


Nuclear Medicine• Strengths

R h t ff ith f i i ll– Research staff with many years of experience in all aspects of radioisotope production and radiopharma-ceutical development

– Strong collaborations with academia and industry to develop agents for molecular imaging

O• Opportunities– Potential for advancement of knowledge in cyclotron

production of radioisotopes at high beam currentsproduction of radioisotopes at high beam currents (with TR-24)

– Potential for additional collaborations in areas of cancer imaging and therapy


Nuclear Medicine– Important therapeutic radionuclides can be made for

evaluation using the ISAC facility and rare-isotopeevaluation using the ISAC facility and rare isotope beams

• Vulnerabilities– Retention / hiring of highly qualified research staff– TR-13 is aging and will need repairs– Adequate base funding required for collaborations

and potential new research directions


Nuclear Medicine Priorities & Plans

• Nuclear Medicine Division is very productive and should be supportedshould be supported– Leverages NRC support to attract additional research

support for radioisotope production and collaborationspp p p• Benefits to Canadian society come from

advances in medical imaging and therapyg g py– Development of cyclotron methods for production of

medically-important radioisotopes can offset the problems / risks associated with reactor productionproblems / risks associated with reactor production

– Potentially become production center for radioisotopes used for PET or SPECT imaging and p g gtherapy (with TR-24)


Technology Transfer


Technology Transfer2. Leading edge activities

Si ifi t tf li f i li d k l d d– Significant portfolio of specialized knowledge and expertise through cutting-edge research in particle physics, nuclear physics, nuclear medicine, materials science, and accelerator science

6. Technology transfer and commercialization– Support to two licensees: Nordion, D-Pace– Maintaining collaboration on medical isotope science:

Nordion BC Cancer Agency Pacific ParkinsonNordion, BC Cancer Agency, Pacific Parkinson Research Center, Genome BC

– Technology transfer of accelerator components: Advanced Cyclotron Systems and PAVAC Industries


Technology Transfer– Canadian companies created or supported through

AAPS: IKOMED CRM Geotomography MicromatterAAPS: IKOMED, CRM Geotomography, Micromatter, GPN Petroleum Technology, Tc-99m Target Commercialization

8. Effectiveness of TRIUMF management– Significant engagement and attention to development

of both industrial partners and technology transferof both industrial partners and technology transfer through AAPS


Tech Transfer Priorities & Plans

• Discovery science remains the primary mission of TRIUMF but emphasis on tech transferof TRIUMF, but emphasis on tech transfer important addition to lab agenda– Development of tech transfer strategy enhancesDevelopment of tech transfer strategy enhances

overall impact of the laboratory’s core capabilities– Evolution of AAPS and role in spawning commercial

ventures appears to be a sound approach– Tc-99m program could have very visible impacts on

economy and health industryeconomy and health industry– Accelerator technology proving to be a second

cornerstone to future economic impacts


Conclusions• TRIUMF has developed, together with the

Canadian subatomic physics community aCanadian subatomic physics community, a scientifically compelling plan for 2015-2020– The plan rests on a foundation of excellenceThe plan rests on a foundation of excellence

demonstrated during the current 5YP• Attracting outside funding & advancing major projects

ff &• Maintaining high operational efficiency & user support• Continuing high impact on important scientific questions• Demonstrably impacting the Canadian economy

– By 2020, TRIUMF would see full exploitation of ARIEL & a realization of the laboratory vision started 5 years ago5 years ago


Conclusions• A budget scenario that reverses the inflationary

erosion of the NRC funding is needed to sustainerosion of the NRC funding is needed to sustain the core TRIUMF program– Allowing full Cyclotron and ARIEL operations, while g y p

completing the ARIEL facility, supporting the ATLAS Tier-1 Center & the full experimental program

Additi l f di ld b j tifi d th b i• Additional funding could be justified on the basis of well-understood & desirable outcomes

Example: Realistic program of basic infrastructure– Example: Realistic program of basic infrastructure investment & proactive facility maintenance

– Example: Investing in the betaNMR and muSRprogram to attract a strong user community


Conclusions– Example: Investing in the Nuclear Medicine program

to reach a sustainable level• Ultimately the 5YP sustains a vision for TRIUMF:

– At the forefront of pursuing fundamental science questions with unique in-house rare-isotope accelerator facilities, while simultaneously providing Canada’s entry into the international pursuit ofCanada s entry into the international pursuit of subatomic physics discovery


view from acot - triumf · view from acot remarks on triumf ... installation and commissioning 2....

Documents